As further support of the reproducibility of our model, we observed that the subcutaneous injection of primary LAM/TSC cells induced cutaneous lesions and follicular neogenesis similarly to what was observed for TSC2-/meth cells. The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.